Iradimed Corp (IRMD): who owns it and who trades it
As of Nov 16, 2026, IRMD insiders reported 107 open-market sales worth $17.1M and no purchases in the last 12 months, with 48% of the sale value made under pre-set 10b5-1 plans. The largest seller was Roger E. Susi (CEO), with $14.6M. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Iradimed
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns IRMD
213 funds and institutions reported IRMD shares worth $756M at the end of Q2 2026, about 62% of the company. The largest holder is BlackRock, Inc. with 7.6%.
Funds and institutions (13F) 62%Everyone else 38%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 967,825 | 7.57% | $92.5M | No change |
| Kayne Anderson Rudnick Investment Management LLC | 396,982 | 3.11% | $37.9M | +14% |
| Renaissance Technologies LLC | 394,412 | 3.09% | $37.7M | -11% |
| Copeland Capital Management, LLC | 391,860 | 3.07% | $37.4M | +9% |
| Vanguard Capital Management LLC | 364,937 | 2.85% | $34.9M | +2% |
| T. Rowe Price Investment Management, Inc. | 318,680 | 2.49% | $30.5M | +24% |
| Geode Capital Management, LLC | 290,109 | 2.27% | $27.7M | +1% |
| Nine Ten Capital Management LLC | 256,562 | 2.01% | $24.5M | -23% |
| Dimensional Fund Advisors LP | 229,340 | 1.79% | $21.9M | +1% |
| State Street Corp | 221,512 | 1.73% | $21.2M | +8% |
| Goldman Sachs Group Inc | 214,151 | 1.68% | $20.5M | +8% |
| Two Sigma Investments, LP | 182,894 | 1.43% | $17.5M | +10% |
| Qube Research & Technologies Ltd | 157,199 | 1.23% | $15M | +88% |
| Royal Bank of Canada | 148,179 | 1.16% | $14.2M | +397% |
| Arrowstreet Capital, Limited Partnership | 143,969 | 1.13% | $13.8M | +832% |
| Northern Trust Corp | 133,658 | 1.05% | $12.8M | +8% |
| Acadian Asset Management LLC | 128,655 | 1.01% | $12.3M | -15% |
| Morgan Stanley | 126,051 | 0.99% | $12M | -16% |
| Vanguard Portfolio Management LLC | 125,357 | 0.98% | $12M | +2% |
| Ranger Investment Management, L.P. | 98,346 | 0.77% | $9.4M | -11% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, IRMD insiders reported $0 of open-market purchases and $17.1M of sales. 48% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Monty K Allen | Director | Sale | 405 | $86.35 | $35K | Form 4 |
| Sep 3, 2026 | Monty K Allen | Director | Sale | 1,014 | $86.44 | $87.7K | Form 4 |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel | Director | Sale | 1,766 | $95.00 | $168K | Form 4 |
| Jun 4, 2026 | Hilda Frederique Scharen-Guivel | Director | Sale | 1,234 | $95.00 | $117K | Form 4 |
| Jun 1, 2026 | Roger E. Susi | CEO | Sale plan | 401 | $91.08 | $36.5K | Form 4 |
| Jun 1, 2026 | Roger E. Susi | CEO | Sale plan | 775 | $89.79 | $69.6K | Form 4 |
| Jun 1, 2026 | Roger E. Susi | CEO | Sale plan | 400 | $88.68 | $35.5K | Form 4 |
| Jun 1, 2026 | Roger E. Susi | CEO | Sale plan | 924 | $91.91 | $84.9K | Form 4 |
| May 27, 2026 | Roger E. Susi | CEO | Sale plan | 333 | $92.61 | $30.8K | Form 4 |
| May 27, 2026 | Roger E. Susi | CEO | Sale plan | 2,167 | $91.85 | $199K | Form 4 |
| May 26, 2026 | Roger E. Susi | CEO | Sale plan | 1,889 | $92.93 | $176K | Form 4 |
| May 26, 2026 | Roger E. Susi | CEO | Sale plan | 3,111 | $91.81 | $286K | Form 4 |
| May 19, 2026 | Roger E. Susi | CEO | Sale plan | 1,841 | $88.14 | $162K | Form 4 |
| May 19, 2026 | Roger E. Susi | CEO | Sale plan | 653 | $87.13 | $56.9K | Form 4 |
| May 19, 2026 | Roger E. Susi | CEO | Sale plan | 6 | $88.65 | $532 | Form 4 |
| May 18, 2026 | Roger E. Susi | CEO | Sale plan | 1,251 | $88.34 | $111K | Form 4 |
| May 18, 2026 | Roger E. Susi | CEO | Sale plan | 3,451 | $87.35 | $301K | Form 4 |
| May 18, 2026 | Roger E. Susi | CEO | Sale plan | 298 | $85.95 | $25.6K | Form 4 |
| May 12, 2026 | Roger E. Susi | CEO | Sale plan | 3,307 | $83.70 | $277K | Form 4 |
| May 12, 2026 | Roger E. Susi | CEO | Sale plan | 1,104 | $84.59 | $93.4K | Form 4 |
| May 11, 2026 | Roger E. Susi | CEO | Sale plan | 1,773 | $84.08 | $149K | Form 4 |
| May 11, 2026 | Roger E. Susi | CEO | Sale plan | 315 | $85.90 | $27.1K | Form 4 |
| May 11, 2026 | Roger E. Susi | CEO | Sale plan | 1,001 | $84.94 | $85K | Form 4 |
| May 5, 2026 | Roger E. Susi | CEO | Sale plan | 600 | $83.78 | $50.3K | Form 4 |
| May 5, 2026 | Roger E. Susi | CEO | Sale plan | 1,322 | $85.56 | $113K | Form 4 |
| May 5, 2026 | Roger E. Susi | CEO | Sale plan | 1,650 | $86.43 | $143K | Form 4 |
| May 5, 2026 | Roger E. Susi | CEO | Sale plan | 178 | $87.31 | $15.5K | Form 4 |
| May 4, 2026 | Roger E. Susi | CEO | Sale plan | 200 | $87.05 | $17.4K | Form 4 |
| May 4, 2026 | Roger E. Susi | CEO | Sale plan | 2,447 | $85.32 | $209K | Form 4 |
| May 4, 2026 | Roger E. Susi | CEO | Sale plan | 1,103 | $86.26 | $95.1K | Form 4 |
| Apr 28, 2026 | Roger E. Susi | CEO | Sale plan | 998 | $84.13 | $84K | Form 4 |
| Apr 28, 2026 | Roger E. Susi | CEO | Sale plan | 847 | $85.77 | $72.6K | Form 4 |
| Apr 28, 2026 | Roger E. Susi | CEO | Sale plan | 742 | $86.52 | $64.2K | Form 4 |
| Apr 28, 2026 | Roger E. Susi | CEO | Sale plan | 900 | $88.00 | $79.2K | Form 4 |
| Apr 28, 2026 | Roger E. Susi | CEO | Sale plan | 263 | $88.81 | $23.4K | Form 4 |
| Apr 27, 2026 | Roger E. Susi | CEO | Sale plan | 2,819 | $88.98 | $251K | Form 4 |
| Apr 27, 2026 | Roger E. Susi | CEO | Sale plan | 931 | $89.70 | $83.5K | Form 4 |
| Apr 21, 2026 | Roger E. Susi | CEO | Sale plan | 140 | $90.60 | $12.7K | Form 4 |
| Apr 21, 2026 | Roger E. Susi | CEO | Sale plan | 1,162 | $89.73 | $104K | Form 4 |
| Apr 21, 2026 | Roger E. Susi | CEO | Sale plan | 592 | $92.66 | $54.9K | Form 4 |
| Apr 21, 2026 | Roger E. Susi | CEO | Sale plan | 606 | $91.65 | $55.5K | Form 4 |
| Apr 20, 2026 | Roger E. Susi | CEO | Sale plan | 1,420 | $93.90 | $133K | Form 4 |
| Apr 20, 2026 | Roger E. Susi | CEO | Sale plan | 3,580 | $93.14 | $333K | Form 4 |
| Apr 14, 2026 | Roger E. Susi | CEO | Sale plan | 2,107 | $93.71 | $197K | Form 4 |
| Apr 14, 2026 | Roger E. Susi | CEO | Sale plan | 393 | $94.55 | $37.2K | Form 4 |
| Apr 13, 2026 | Roger E. Susi | CEO | Sale plan | 589 | $93.45 | $55K | Form 4 |
| Apr 13, 2026 | Roger E. Susi | CEO | Sale plan | 2,564 | $92.79 | $238K | Form 4 |
| Apr 13, 2026 | Roger E. Susi | CEO | Sale plan | 1,847 | $91.84 | $170K | Form 4 |
| Apr 7, 2026 | Roger E. Susi | CEO | Sale plan | 982 | $95.58 | $93.9K | Form 4 |
| Apr 7, 2026 | Roger E. Susi | CEO | Sale plan | 1,518 | $94.36 | $143K | Form 4 |
| Apr 6, 2026 | Roger E. Susi | CEO | Sale plan | 569 | $96.78 | $55.1K | Form 4 |
| Apr 6, 2026 | Roger E. Susi | CEO | Sale plan | 3,074 | $96.24 | $296K | Form 4 |
| Apr 6, 2026 | Roger E. Susi | CEO | Sale plan | 1,357 | $95.21 | $129K | Form 4 |
| Mar 30, 2026 | Roger E. Susi | CEO | Sale plan | 155 | $96.53 | $15K | Form 4 |
| Mar 30, 2026 | Roger E. Susi | CEO | Sale plan | 1,497 | $95.66 | $143K | Form 4 |
| Mar 30, 2026 | Roger E. Susi | CEO | Sale plan | 5,848 | $94.81 | $554K | Form 4 |
| Mar 24, 2026 | Roger E. Susi | CEO | Sale | 915 | $100.71 | $92.1K | Form 4 |
| Mar 24, 2026 | Roger E. Susi | CEO | Sale | 1,585 | $100.03 | $159K | Form 4 |
| Mar 23, 2026 | Roger E. Susi | CEO | Sale | 750 | $100.70 | $75.5K | Form 4 |
| Mar 23, 2026 | Roger E. Susi | CEO | Sale | 2,950 | $99.58 | $294K | Form 4 |
| Mar 23, 2026 | Roger E. Susi | CEO | Sale | 1,300 | $102.02 | $133K | Form 4 |
| Mar 17, 2026 | Roger E. Susi | CEO | Sale | 2,500 | $102.43 | $256K | Form 4 |
| Mar 16, 2026 | Roger E. Susi | CEO | Sale | 3,009 | $101.18 | $304K | Form 4 |
| Mar 16, 2026 | Roger E. Susi | CEO | Sale | 1,991 | $101.68 | $202K | Form 4 |
| Mar 10, 2026 | Roger E. Susi | CEO | Sale | 2,500 | $100.11 | $250K | Form 4 |
| Mar 9, 2026 | Roger E. Susi | CEO | Sale | 5,000 | $100.04 | $500K | Form 4 |
| Mar 6, 2026 | Roger E. Susi | CEO | Sale | 1,200 | $99.12 | $119K | Form 4 |
| Mar 6, 2026 | Roger E. Susi | CEO | Sale | 6,300 | $98.25 | $619K | Form 4 |
| Feb 13, 2026 | Monty K Allen | Director | Sale | 1,000 | $100.26 | $100K | Form 4 |
| Jan 26, 2026 | Roger E. Susi | CEO | Sale | 661 | $101.38 | $67K | Form 4 |
| Jan 26, 2026 | Roger E. Susi | CEO | Sale | 4,339 | $100.54 | $436K | Form 4 |
| Jan 20, 2026 | Roger E. Susi | CEO | Sale | 2,129 | $101.03 | $215K | Form 4 |
| Jan 20, 2026 | Roger E. Susi | CEO | Sale | 1,074 | $102.03 | $110K | Form 4 |
| Jan 20, 2026 | Roger E. Susi | CEO | Sale | 1,797 | $102.70 | $185K | Form 4 |
| Jan 12, 2026 | Roger E. Susi | CEO | Sale | 112 | $98.15 | $11K | Form 4 |
| Jan 12, 2026 | Roger E. Susi | CEO | Sale | 4,888 | $97.43 | $476K | Form 4 |
| Jan 5, 2026 | Roger E. Susi | CEO | Sale | 2,209 | $98.42 | $217K | Form 4 |
| Jan 5, 2026 | Roger E. Susi | CEO | Sale | 883 | $97.52 | $86.1K | Form 4 |
| Jan 5, 2026 | Roger E. Susi | CEO | Sale | 300 | $95.58 | $28.7K | Form 4 |
| Jan 5, 2026 | Roger E. Susi | CEO | Sale | 854 | $95.10 | $81.2K | Form 4 |
| Jan 5, 2026 | Roger E. Susi | CEO | Sale | 754 | $99.48 | $75K | Form 4 |
| Dec 29, 2025 | Roger E. Susi | CEO | Sale | 4,899 | $97.65 | $478K | Form 4 |
| Dec 29, 2025 | Roger E. Susi | CEO | Sale | 101 | $98.31 | $9.9K | Form 4 |
| Dec 22, 2025 | Roger E. Susi | CEO | Sale | 1,228 | $97.70 | $120K | Form 4 |
| Dec 22, 2025 | Roger E. Susi | CEO | Sale | 3,772 | $96.42 | $364K | Form 4 |
| Dec 15, 2025 | Roger E. Susi | CEO | Sale | 4,269 | $96.68 | $413K | Form 4 |
| Dec 15, 2025 | Roger E. Susi | CEO | Sale | 731 | $97.13 | $71K | Form 4 |
| Dec 11, 2025 | John Glenn | CFO | Sale | 14,468 | $97.26 | $1.4M | Form 4 |
| Dec 11, 2025 | John Glenn | CFO | Sale | 532 | $98.09 | $52.2K | Form 4 |
| Dec 9, 2025 | James B Hawkins | Director | Sale | 3,000 | $96.61 | $290K | Form 4 |
| Dec 8, 2025 | Roger E. Susi | CEO | Sale plan | 126 | $97.61 | $12.3K | Form 4 |
| Dec 8, 2025 | Roger E. Susi | CEO | Sale plan | 100 | $98.24 | $9.8K | Form 4 |
| Dec 8, 2025 | Roger E. Susi | CEO | Sale plan | 4,684 | $95.30 | $446K | Form 4 |
| Dec 8, 2025 | Roger E. Susi | CEO | Sale plan | 90 | $96.17 | $8.7K | Form 4 |
| Dec 1, 2025 | Roger E. Susi | CEO | Sale plan | 3,324 | $92.97 | $309K | Form 4 |
| Dec 1, 2025 | Roger E. Susi | CEO | Sale plan | 1,676 | $92.34 | $155K | Form 4 |
| Nov 24, 2025 | Roger E. Susi | CEO | Sale plan | 556 | $89.67 | $49.9K | Form 4 |
| Nov 24, 2025 | Roger E. Susi | CEO | Sale plan | 3,558 | $90.31 | $321K | Form 4 |
| Nov 24, 2025 | Roger E. Susi | CEO | Sale plan | 886 | $91.01 | $80.6K | Form 4 |
| Nov 20, 2025 | James B Hawkins | Director | Sale | 100 | $88.28 | $8.8K | Form 4 |
Latest 100 of 107 trades in the last 12 months.
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Roger E. Susi | CEO, PRESIDENT, CHAIRMAN, Director, 10% owner | – | $14.6M | Jun 1, 2026 |
| John Glenn | CHIEF FINANCIAL OFFICER | – | $1.5M | Dec 11, 2025 |
| James B Hawkins | Director | – | $555K | Dec 9, 2025 |
| Hilda Frederique Scharen-Guivel | Director | – | $285K | Jun 4, 2026 |
| Monty K Allen | Director | – | $223K | Sep 3, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
IRMD short interest
Low short interest. 4.6% of IRMD shares are sold short: about 1 share in 22. Over the last 12 reports the number of shares short went down 11%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 590,054 IRMD shares were sold short, 4.6% of the shares outstanding, down 12.0% from the report before. At the average daily volume of 115,775 shares, buying them all back would take about 5.1 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 590,054 | 4.61% | -12% | 115,775 | 5.1 |
| Oct 15, 2026 | 670,183 | 5.24% | +2% | 108,451 | 6.2 |
| Sep 30, 2026 | 657,367 | 5.14% | -6% | 146,217 | 4.5 |
| Sep 15, 2026 | 700,005 | 5.47% | +0% | 122,798 | 5.7 |
| Aug 31, 2026 | 697,251 | 5.45% | -4% | 83,253 | 8.4 |
| Aug 14, 2026 | 727,749 | 5.69% | +9% | 150,656 | 4.8 |
| Jul 31, 2026 | 670,183 | 5.24% | -5% | 116,157 | 5.8 |
| Jul 15, 2026 | 705,832 | 5.52% | +3% | 140,576 | 5.0 |
| Jun 30, 2026 | 685,974 | 5.37% | +1% | 141,364 | 4.8 |
| Jun 15, 2026 | 681,716 | 5.33% | +4% | 154,198 | 4.4 |
| May 29, 2026 | 652,970 | 5.11% | -1% | 156,280 | 4.2 |
| May 15, 2026 | 661,120 | 5.17% | +21% | 119,480 | 5.5 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Iradimed company events
Iradimed filed 7 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Oct 30, 2026.
- Oct 30, 2026ResultsReleased financial results. Filing
- Aug 18, 2026ResultsAmended an earlier report. Released financial results. Filing
- Jul 31, 2026AnnouncementMade another announcement. Filing
- Jun 24, 2026VoteReported shareholder vote results. Filing
- May 1, 2026ResultsReleased financial results. Filing
- Feb 10, 2026ResultsReleased financial results. Filing
- Dec 8, 2025AnnouncementThe Board of Directors of IRADIMED CORPORATION declared a special cash dividend on the Company's outstanding common stock of $0.50 per share. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Iradimed financials
Famous investors that hold IRMD
5 of the 50 well-known investors we track reported holding IRMD in their latest 13F filing. The largest position is Jim Simons's, worth $30.2M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 350,612 | $30.2M | 0.0% | -11% |
| Israel Englander · Millennium Management | Q3 2026 | 69,734 | $6M | 0.0% | New |
| Ken Griffin · Citadel Advisors | Q3 2026 | 45,243 | $3.9M | 0.0% | New |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 33,879 | $2.9M | 0.0% | -26% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 21,589 | $1.9M | 0.0% | +81% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named IRMD in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 27, 2026 | BlackRock, Inc. | 13G/A | 5.0% |
| Oct 27, 2026 | BlackRock, Inc. | 13G/A | 5.0% |
Questions about Iradimed Corp (IRMD) stock
Who owns the most IRMD stock?
The largest reported owner of Iradimed Corp (IRMD) is BlackRock, Inc., with 7.6% of the company. In total, 213 funds and institutions reported holding IRMD at the end of Q2 2026, together about 62% of the shares. See the largest owners.
Are IRMD insiders buying or selling?
In the last 12 months, IRMD insiders reported no open-market purchases and 107 sales worth $17.1M. The latest trade was on Sep 3, 2026. See every trade.
What is the short interest in IRMD?
As of Oct 30, 2026, 590,054 IRMD shares were sold short, 4.6% of the shares outstanding, down 12.0% from the report before. At the average daily volume of 115,775 shares, buying them all back would take about 5.1 trading days (days to cover). See the history.
Which famous investors hold IRMD?
5 of the 50 well-known investors we track reported IRMD in their latest 13F filing, including Jim Simons, Israel Englander, Ken Griffin. The largest position is worth $30.2M. See all holders.
Executive pay
Iradimed's chief executive was paid a total of $781K for the year ended Dec 31, 2025, up 13% from $690K the year before. In the last 12 months, Iradimed's executives and directors bought no stock on the open market and sold $17.1M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.